CGOCX | NRGEX | CGOCX / NRGEX | |
Total Expense Ratio | 1.99 | 0.03 | 6,633% |
Annual Report Gross Expense Ratio | 2.00 | 0.69 | 290% |
Fund Existence | 20 years | 4 years | - |
Gain YTD | 12.555 | 0.214 | 5,876% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2000 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 2.61B | 9.24B | 28% |
Annual Yield % from dividends | 0.00 | 0.53 | - |
Returns for 1 year | 24.62 | 1.06 | 2,312% |
Returns for 3 years | 66.67 | 11.09 | 601% |
Returns for 5 years | 10.90 | N/A | - |
Returns for 10 years | -19.02 | N/A | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
WSTRX | 55.32 | 0.41 | +0.75% |
Macquarie Science and Technology R | |||
NEQAX | 12.87 | 0.06 | +0.47% |
Neuberger Berman U.S. Equity Impact A | |||
CIPNX | 22.60 | 0.05 | +0.22% |
Champlain Small Company Institutional | |||
SCVAX | 36.48 | 0.02 | +0.05% |
Allspring Small Company Value A | |||
DNLVX | 21.35 | -0.04 | -0.19% |
Dunham Large Cap Value N |